Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)
2014 · Annals of Oncology · 137 citations
https://doi.org/10.1093/annonc/mdu455
M
Mustafa Deryal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
937
Citations
9
h-index
9
i10-index
Mustafa Deryal is an academic researcher from cts CaritasKlinikum Saarbrücken. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 9, co-authored 34 publications.
ORCID: 0009-0001-4634-2378Papers by this author
worksSafety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
2017 · European Journal of Cancer · 46 citations
https://doi.org/10.1016/j.ejca.2017.05.010
DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
2013 · Clinical Epigenetics · 33 citations
https://doi.org/10.1186/1868-7083-5-7
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2023 · British Journal of Cancer · 25 citations
https://doi.org/10.1038/s41416-022-02108-7
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects
2025 · EBioMedicine · 3 citations
https://doi.org/10.1016/j.ebiom.2025.105764
NOGGO Ov50 - GRACE Switching From A Phase IV Trial To A Qualitative Analysis: Rucaparib The Management Of Ovarian Cancer
2025 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2024.101177
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat